These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36129816)

  • 1. Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention.
    Bashar H; Matetić A; Curzen N; Mamas MA
    Catheter Cardiovasc Interv; 2022 Nov; 100(5):737-746. PubMed ID: 36129816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of acute coronary syndrome patients with concurrent extra-cardiac vascular disease in the era of transradial coronary intervention: A retrospective multicenter cohort study.
    Kodaira M; Sawano M; Kuno T; Numasawa Y; Noma S; Suzuki M; Imaeda S; Ueda I; Fukuda K; Kohsaka S
    PLoS One; 2019; 14(10):e0223215. PubMed ID: 31618228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of Extracardiac Vascular Disease and Outcomes in Patients With Diabetes (1.1 Million) Hospitalized for Acute Myocardial Infarction.
    Istanbuly S; Matetic A; Roberts DJ; Myint PK; Alraies MC; Van Spall HG; Mohamed MO; Bharadwaj A; Mamas MA
    Am J Cardiol; 2022 Jul; 175():8-18. PubMed ID: 35550818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Impact of Type 1 and Type 2 Diabetes Mellitus on Outcomes Among 1.4 Million US Patients Undergoing Percutaneous Coronary Intervention.
    Matetic A; Doolub G; Bharadwaj A; Osman M; Biondi-Zoccai G; Ullah W; Bagur R; Velagapudi P; Alraies MC; Mohamed MO; Mamas MA
    Cardiovasc Revasc Med; 2022 May; 38():83-88. PubMed ID: 34446373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of extracardiac vascular disease on vein graft failure and outcomes after coronary artery bypass surgery.
    Harskamp RE; Alexander JH; Schulte PJ; Jones WS; Williams JB; Mack MJ; Peterson ED; Gibson CM; Califf RM; Kouchoukos NT; Ferguson TB; de Winter RJ; Lopes RD
    Ann Thorac Surg; 2014 Mar; 97(3):824-30. PubMed ID: 24360877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL Trial.
    Diamond J; Madhavan MV; Sabik JF; Serruys PW; Kappetein AP; Leon MB; Taggart DP; Berland J; Morice MC; Gersh BJ; Kandzari DE; Dressler O; Stone GW
    JACC Cardiovasc Interv; 2018 Dec; 11(24):2441-2450. PubMed ID: 30573053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?
    Mamas MA; Ratib K; Routledge H; Neyses L; Fraser DG; de Belder M; Ludman PF; Nolan J;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):698-706. PubMed ID: 23769648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive Management and In-Hospital Outcomes of Myocardial Infarction Patients in Rural Versus Urban Hospitals in the United States.
    Bashar H; Matetić A; Curzen N; Mamas MA
    Cardiovasc Revasc Med; 2023 Jan; 46():3-9. PubMed ID: 36038495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Outcome of patients with coronary artery disease and left ventricular ejection fraction less than 50% undergoing percutaneous coronary intervention].
    Jiang L; Song Y; Xu JJ; Tang XF; Wang HH; Jiang P; Gao LJ; Song L; Gao Z; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1058-1066. PubMed ID: 29325366
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic significance of prior ischemic stroke in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Wang H; Ning X; Zhu C; Yin D; Feng L; Xu B; Guan C; Dou K
    Catheter Cardiovasc Interv; 2019 Feb; 93(S1):787-792. PubMed ID: 30618111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease.
    Mahmoud AN; Elgendy IY; Mentias A; Saad M; Ibrahim W; Mojadidi MK; Nairooz R; Eshtehardi P; David Anderson R; Samady H
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):541-552. PubMed ID: 28296170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with reduced ejection fraction.
    Bianco V; Kilic A; Mulukutla S; Gleason TG; Kliner D; Allen CC; Habertheuer A; Aranda-Michel E; Humar R; Navid F; Wang Y; Sultan I
    J Thorac Cardiovasc Surg; 2021 Mar; 161(3):1022-1031.e5. PubMed ID: 33059935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular disease burden and in-hospital outcomes among patients undergoing percutaneous coronary intervention in New York State.
    Berger JS; Petersen JL; Brown DL
    Circ Cardiovasc Interv; 2009 Aug; 2(4):317-22. PubMed ID: 20031734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.
    Secemsky EA; Yeh RW; Kereiakes DJ; Cutlip DE; Steg PG; Massaro JM; Apruzzese PK; Mauri L;
    JACC Cardiovasc Interv; 2017 May; 10(9):942-954. PubMed ID: 28473118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of short-time anticoagulant therapy after selective percutaneous intervention on prognosis of patients with coronary artery disease].
    Song Y; Tang XF; Xu JJ; Wang HH; Liu R; Jiang P; Jiang L; Gao LJ; Zhang Y; Song L; Xu LJ; Zhao XY; Gao Z; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Feb; 47(2):108-116. PubMed ID: 30818938
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of Outcomes of Patients With Versus Without Chronic Liver Disease Undergoing Percutaneous Coronary Intervention.
    Istanbuly S; Matetic A; Mohamed MO; Panaich S; Velagapudi P; Elgendy IY; Paul TK; Alkhouli M; Mamas MA
    Am J Cardiol; 2021 Oct; 156():32-38. PubMed ID: 34348842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Chronic Thrombocytopenia on In-Hospital Outcomes After Percutaneous Coronary Intervention.
    Ayoub K; Marji M; Ogunbayo G; Masri A; Abdel-Latif A; Ziada K; Vallurupalli S
    JACC Cardiovasc Interv; 2018 Sep; 11(18):1862-1868. PubMed ID: 30172792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention.
    Loncar G; Barthelemy O; Berman E; Kerneis M; Petroni T; Payot L; Choussat R; Silvain J; Collet JP; Helft G; Montalescot G; Le Feuvre C
    Arch Cardiovasc Dis; 2015 Nov; 108(11):554-62. PubMed ID: 26184868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.